Navigation Links
New Blood Thinner Effient No Better Than Plavix at Preventing Heart Trouble: Study
Date:8/27/2012

By Amanda Gardner
HealthDay Reporter

SUNDAY, Aug. 26 (HealthDay News) -- The newer blood thinner Effient is no more effective than the widely used Plavix in preventing death, heart attacks or strokes, new research finds.

Nor is Effient (prasugrel) any safer than Plavix (clopidogrel) when it comes to bleeding complications in patients with acute coronary syndrome who have not had revascularization procedures such as bypass surgery or stenting.

The findings are scheduled to be presented Sunday at the European Society of Cardiology annual meeting in Munich and simultaneously published online in the New England Journal of Medicine.

The study was funded by Eli Lilly and Co. and Daiichi Sankyo Co., which co-developed Effient.

Acute coronary syndrome (ACS) includes heart attacks and other conditions, such as angina, which result from blocked coronary arteries.

Roughly 60 percent of patients with ACS undergo revascularization procedures to restore blood flow to the heart while the remaining 40 percent are managed by medications alone, the researchers said.

A previous trial of more than 13,000 ACS patients who were about to receive stents found that Effient was about 20 percent more effective than Plavix in preventing death, heart attacks and stroke. However, Effient also resulted in more cases of fatal bleeding.

This study was designed to look at a completely different group of ACS patients: those who did not undergo a revascularization procedure.

"This group of patients has never been exclusively studied before in a large-scale trial," said study author Dr. Matthew Roe, an associate professor of medicine at Duke University Medical Center in Durham, N.C.

Roe and other study authors reported financial ties with Eli Lilly, Daiichi Sankyo and other pharmaceutical companies.

For this study, 7,243 patients in 52 countries were randomized to receive 10 milligrams daily of Effient or 75 milligrams a day of Plavix. Both groups also took aspirin.

After an average follow-up of 17 months, 14 percent of patients receiving Effient died or had a heart attack or stroke, compared with 16 percent of those taking Plavix, not a statistically significant difference.

There was, however, some improvement in some health outcomes beyond the one-year mark in patients under the age of 75 taking Effient, the authors noted.

"There may be some patients who benefit for the longer term with platelet inhibitors," Roe said. "These patients that do not undergo revascularization may be fundamentally different from those who do [and] may need treatment longer. The exact reasons are not certain."

Plavix has the additional advantage of being inexpensive -- as little as about $35 for a month's supply since the drug went generic in May. Effient, on the other hand, can cost hundreds of dollars a month.

One expert noted that might make the difference when it comes to deciding which to prescribe for this group of patients.

"In the long run, it's going to come down to cost," said Dr. Christopher Cove, assistant director of the cardiac catheterization lab at the University of Rochester Medical Center. "Now that clopidogrel is generic, it's going to be tougher to prescribe a drug that's going to cost a lot more money without significant benefits."

More information

The Mayo Clinic has more on acute coronary syndrome.

SOURCES: Matthew Roe, M.D., associate professor, medicine, Duke University Medical Center, Durham, N.C.; Christopher Cove, M.D., associate professor, medicine, and assistant director, cardiac catheterization lab, University of Rochester Medical Center, New York; Aug. 26, 2012, New England Journal of Medicine, online; Aug. 26, 2012, presentation, European Society of Cardiology annual meeting, Munich


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Infection Might Raise Blood Clot Risk for Older Adults: Study
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. Common Blood Pressure Drug Safe for Heart Failure: Study
4. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
5. High Blood Pressure May Be Especially Lethal for Blacks
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Researchers Develop Blood Test for Depression
8. Naturopathic care can improve blood sugar, mood in diabetes
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Exercise May Help Patients With High Blood Pressure Live Longer
11. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Blood Thinner Effient No Better Than Plavix at Preventing Heart Trouble: Study
(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance Group, ... to communities across North Carolina, is launching a charity event in conjunction with ... for the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy Network ...
(Date:7/25/2017)... (PRWEB) , ... July 25, 2017 , ... ... Health, as medical director. Dr. Negrette has more than a decade of experience ... has worked closely with individuals fighting addictions, eating disorders, psychotic and manic conditions, ...
(Date:7/24/2017)... ... , ... Engineers at the University of Maryland have invented an entirely new ... energy that the body uses. , In ordinary batteries the electrical energy, or ... of the battery is generated by moving positive ions from one end to the ...
(Date:7/24/2017)... ... 2017 , ... Cosmetic Town, an online plastic surgery information community, announces a ... a daily basis. , The new video series will feature board-certified doctors explaining ... practices. , When asked about the new video series, the senior editor of ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... scholarship awards to be awarded annually to and divided between two full-time university ... bringing awareness to Amazonian plant medicine. To apply for the scholarship, students are ...
Breaking Medicine News(10 mins):
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
(Date:7/14/2017)... 13, 2017 It should come as no surprise ... is in the midst of a crippling opioid epidemic. According ... the number of overdose deaths from opiate-based medications has quadrupled, ... a million dead from 2001 to 2015". During this time, ... has similarly quadrupled, drawing a compelling link between prescription and ...
(Date:7/13/2017)... -- RK Logistics Group, Inc. was awarded California ... Fremont, CA headquarters facility where it provides ... San Jose for hi-tech, pharmaceutical and biomedical ... with its Fremont Innovation District, is excited to strategically partner ... to the hundreds of biotech, pharma and biomed companies throughout ...
Breaking Medicine Technology: